Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human GLUT1 Antikörper:
anti-Mouse (Murine) GLUT1 Antikörper:
anti-Rat (Rattus) GLUT1 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal GLUT1 Primary Antibody für ChIP, FACS - ABIN258123
Hergovich, Lisztwan, Thoma, Wirbelauer, Barry, Krek: Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3. in Molecular and cellular biology 2006
Show all 22 Pubmed References
Human Polyclonal GLUT1 Primary Antibody für ELISA, ICC - ABIN152817
Minamishima, Moslehi, Bardeesy, Cullen, Bronson, Kaelin: Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. in Blood 2008
Show all 21 Pubmed References
Human Monoclonal GLUT1 Primary Antibody für CyTOF, FACS - ABIN4899145
Jain, Manuel, Khan, Ahuja, Quann, Wigdahl: DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells. in Journal of virology 2009
Show all 9 Pubmed References
Human Monoclonal GLUT1 Primary Antibody für FACS - ABIN4895661
Patsoukis, Bardhan, Chatterjee, Sari, Liu, Bell, Karoly, Freeman, Petkova, Seth, Li, Boussiotis: PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. in Nature communications 2015
Show all 5 Pubmed References
Human Monoclonal GLUT1 Primary Antibody für FACS - ABIN4895663
Prost, Relouzat, Spentchian, Ouzegdouh, Saliba, Massonnet, Beressi, Verhoeyen, Raggueneau, Maneglier, Castaigne, Chomienne, Chrétien, Rousselot, Leboulch: Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists. in Nature 2015
Show all 3 Pubmed References
Human Monoclonal GLUT1 Primary Antibody für FACS - ABIN4895662
Feldhoff, Rueda, Moreno-Fernandez, Sauer, Jackson, Chougnet, Rupp: IL-1β induced HIF-1α inhibits the differentiation of human FOXP3+T cells. in Scientific reports 2017
Show all 2 Pubmed References
Human Polyclonal GLUT1 Primary Antibody für FACS, ICC - ABIN5076961
Rodríguez-Espinosa, Rojas-Espinosa, Moreno-Altamirano, López-Villegas, Sánchez-García: Metabolic requirements for neutrophil extracellular traps formation. in Immunology 2015
Show all 2 Pubmed References
Human Monoclonal GLUT1 Primary Antibody für FACS - ABIN4895659
Palmer, Ostrowski, Gouillou, Tsai, Yu, Zhou, Henstridge, Maisa, Hearps, Lewin, Landay, Jaworowski, McCune, Crowe: Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection. in AIDS 2014
Show all 2 Pubmed References
Human Polyclonal GLUT1 Primary Antibody für ELISA, ICC - ABIN6261994
Li, Feng, Wei, Liu, Yang, Hou, Zhao, Zhang, Yang: The Aqueous Extract of Gynura divaricata (L.) DC. Improves Glucose and Lipid Metabolism and Ameliorates Type 2 Diabetes Mellitus. in Evidence-based complementary and alternative medicine : eCAM 2018
Corticotropin releasing hormone and 8-Br-cAMP led to robust GLUT1 upregulation and increased membrane translocation.
Placental expression of at least three GLUT isoforms, i.e. GLUT-1, GLUT-4, and GLUT-9, may be involved in the intensification of intrauterine fetal growth in pregnancies complicated by gestational diabetes mellitus and pregnancy complicated by diabetes mellitus, type 1.
Besides GLUT1, GLUT5 seems to be regulated under hypoxia.
High glut1 expression is associated with Malignant Melanoma.
This study provides evidence that SLC2A1 gene variants might be implicated in the development of Type 2 diabetes microvascular complications.
A positive expression of GLUT1 significantly predicts a poor prognosis in lung cancer patients. GLUT1 may server as a helpful biomarker and a potential target for the treatment strategies of lung cancer.[review;meta-analysis]
SLC2A1 gene variants do not play a causative role in genetic generalized epilepsy patients with eyelid myoclonia.
The gene changes of SLC2A1 pathogenic variants leading to GLUT1 deficiency and generalized epilepsies.
genetic variation in GLUT1 is associated with Early-Stage Non-small Cell Lung Cancer.
This meta-analysis indicates that GLUT1 expression is associated with poor prognostic and a series of clinicopathological features in breast cancer
The distribution of glucose transporter 1 expression compared with heme oxygenase 1 expression in HCT116 cell spheroids seemed consistent with differential dependence of hypoxic expression of these molecules on fatty acid beta-oxidation
SLC2A1 variants and haplotypes may be involved in the pathogenesis of diabetic nephropathy [meta-analysis]
These findings promote development of metabolic-based cancer detection technologies, and suggest that 2GF-GNPs may enable specific cancer detection in a wide range of tumors characterized by high GLUT-1 expression
Kazakh and Han patients with esophageal squamous cell carcinoma with Glut1 c-myc co-expression had poorer prognosis.
miR-328 expression is reduced in colon cancer patients and thus inversely correlates with the classically reported upregulated SLC2A1/GLUT1 expression in tumors.
Glucose transporter-1 could play a role not only in the onset of psoriasis but also in the progression and severity of the disease. It may participate in the pathogenesis of psoriasis through the facilitation of epidermal hyperproliferation, inflammation, and angiogenesis.
Data suggest that GLUT1 functions as tetramer of adjacent dimers of allosteric, alternating access transporters in which (a) cis-allostery is mediated by intra-subunit interaction and (b) trans-allostery requires inter-subunit interaction. Endofacial (vs exofacial) cis-allostery obtains when affinity of un-liganded e1 (endofacial) GLUT1 subunit in one dimer is increased by occupancy of e1 GLUT1 subunit of adjacent dimer.
Results show that GLUT1 is sensitive and specific marker for colorectal cancer (CRC). It is overexpressed in young age patients, poor performance status, and stage IV patients. Although this was not statistically significant, GLUT 1 showed higher expression level in patients with lesser survival.
GLUT1 ectopic overexpression makes PCa cells more resistant to glucose deprivation and oxidative stress-induced cell death. Under glucose deprivation, GLUT1 overexpressing PCa cells sustains mitochondrial SOD2 activity, compromised after glucose removal, and significantly increases reduced glutathione (GSH)
Results confirm the positive expression of Glut1 in colorectal neoplasm (CRC) and its involvement in proliferation and cell survival of cancer cells. Its silencing inhibits the proliferation and promoted apoptosis of CRC cells by inactivating TGF-beta/PI3K-AKT-mTOR signaling pathway.
AQP7 and GLUT1 mRNA and protein have a higher expression in T1DM mice, but the levels of AQP9 mRNA and protein are not changed in the lung difference between normal and T1DM mice. T1DM may increase the expression of transporters of trivalent inorganic arsenic.
Biochemical studies identify a Bmp-mTORC1-Hif1a signaling cascade resulting in upregulation of Glut1 in chondrocytes that is essential for murine skeletal development.
Adequate Glut1 protein is indispensable for the proper development and maintenance of the capillary network of the brain.
Immunoreactivity of vGluT1 in continuous theta-burst stimulation (iTBS; cTBS) repeated session (RS) decreased, while GLT-1 increased in cTBS SS and cTBS RS, compared to control
Expression of GLUT1 is stimulated by hyperglycemia and low oxygen supply, and this overexpression was associated with increased activity of GLUT1 in the cell membrane that contributes to the impairment of the RPE secretory function of PEDF.
GLUT1 may play an important role in Prostate Cancer progression via mediating glycolysis and proliferation. There is potential crosstalk between GLUT1-mediated glycolysis and androgen sensitivity in Prostate Cancer.
ARAP2 knockdown did not affect fatty acid uptake but reduced basal glucose uptake, total levels of the glucose transporter GLUT1, and GLUT1 levels in the plasma membrane and the lipid micro-domain fraction.
TBC1D5 shuttling to autophagosomes during metabolic stress facilitates retromer-dependent GLUT1 trafficking.
inhibition of GLUT1 activity and/or expression is shown to impair TGF-beta-driven fibrogenic processes, including cell proliferation and production of profibrotic mediators
B cell leukemia-induced inhibition of T cell Akt/mTORC1 signaling and glucose metabolism drives T cell dysfunction; metabolic defects included reduced Akt/mammalian target of rapamycin complex 1 (mTORC1) signaling, decreased expression of the glucose transporter Glut1 and hexokinase 2, and reduced glucose uptake
This study demonstrates a strict requirement for GLUT1 in the early stages of mammary tumorigenesis in vitro and in vivo.
GLUT1-dependent glycolysis regulates fibrogenesis in aged lung.
Data (including data from studies using transgenic mice) suggest that Glut1 (glucose transporter type 1) is a critical downstream target of Hif1a (hypoxia-inducible factor 1, alpha subunit) mediating hyperglycemia-induced extracellular matrix accumulation in kidney via regulation of Nox4 (NADPH oxidase type 4) expression in nephropathy due to diabetes type 1.
CRISPR/Cas9-mediated disruption of the Hdac2 gene increased Slc2a1 expression, suggesting that it is one of the responsible histone deacetylases (HDACs). These results confirm that b-OHB is a HDAC inhibitor and show that b-OHB plays an important role in fasting-induced epigenetic activation of a glucose transporter gene in the brain.
Taken together, the data suggest that curcumin binds directly to GLUT1 at a site that overlaps with the cytochalasin B binding site and thereby inhibits glucose transport.
overnutrition during early life induces short-term metabolic disturbances, impairment in heart insulin signaling, up-regulates GLUT-1 and switch cardiac fuel preference in juvenile mice
alpha(1)-AR activation is anti-apoptotic and protective during cardiac ischemia due to glucose deprivation and not hypoxia by enhancing glucose uptake into the heart via PKCdelta-mediated GLUT translocation that may be specific to the alpha(1A)-AR subtype.
Glut1 connects the enhanced glucose uptake in atheromatous plaques of ApoE(-/-) mice with their myelopoiesis through regulation of hematopoietic stem and multipotential progenitor cell maintenance and myelomonocytic fate.
Enhanced GLUT1 expression in melanoma cells favors their metastatic behavior.
pGlcT, together with MEX1, contributes significantly to the export of starch degradation products from chloroplasts in A. thaliana leaves and and that this starch-mediated pathway for photoassimilate export via pGlcT and MEX1 is essential for the growth and development of A. thaliana. [pGlcT]
Low GLUT1 and GLUT3 expression in nonclassical monocytes was unaltered during differentiation into macrophages. GLUT4 mRNA was only detectable in unstimulated macrophages. Neither monocytes nor macrophages were insulin responsive.
the different conformations of the GLUT-1 transporter in luminal (blood facing) and abluminal (brain facing) membranes of bovine cerebral endothelial cells arise from differential phosphorylation of GLUT-1
Significant increases in GLUT1 gene expression were observed during early lactation.
Hyperthermia-induced Hsp90.eNOS preserves mitochondrial respiration in hyperglycemic endothelial cells by down-regulating Glut-1 and up-regulating G6PD activity.
distinct regulation by glucose deprivation in chromaffin cells
distinct domains of the glucose transporter GLUT1 mediate HTLV envelope binding and virus entry
Expression of GLUT1 was evaluated in LLC-PK1 cells grown on porous membranes for the development of an artificial kidney.
results suggest that glucose is transported to the axonal cleft intracytoplasmically and delivered to the cleft by GLUT1 transporters
This gene encodes a major glucose transporter in the mammalian blood-brain barrier. The encoded protein is found primarily in the cell membrane and on the cell surface, where it can also function as a receptor for human T-cell leukemia virus (HTLV) I and II. Mutations in this gene have been found in a family with paroxysmal exertion-induced dyskinesia.
, glucose transporter type 1, erythrocyte/brain
, hepG2 glucose transporter
, human T-cell leukemia virus (I and II) receptor
, solute carrier family 2, facilitated glucose transporter member 1
, solute carrier family 2, member 1
, Solute carrier family 2 a 1 (facilitated glucose transporter) brain
, Solute carrier family 2, facilitated glucose transporter member 1
, solute carrier family 2 (facilitated glucose transporter), member 1
, solute carrier family 2 member 1
, glucose transporter protein
, glucose transporter type 1
, solute carrier family 2 (facilitated glucose transporter), member 1 L homeolog
, glucose transport protein